CSPG4 Could Make CAR T-Cell Therapy a Reality in Treating Glioblastoma – AJMC.com Managed Markets Network
|
CSPG4 Could Make CAR T-Cell Therapy a Reality in Treating Glioblastoma
AJMC.com Managed Markets Network The researchers concluded that these data support the potential of achieving clinical benefits by using CAR T cells in patients with glioblastoma and highlight CSPG4 as an attractive target for immunotherapy in this indication. Although a combination … |
